Liminatus Pharma(LIMN.US)

Last Updated 19:00:00 ET
longbridge loading

12 Health Care Stocks Moving In Wednesday's After-Market Session

benzinga_article·
US
SDEV
-1.94%
US
GELS
+16.66%
US
PHGE
+59.60%
benzinga_article·
US
SDEV
-1.94%
US
GELS
+16.66%
US
PHGE
+59.60%

12 Health Care Stocks Moving In Thursday's Intraday Session

benzinga_article·
US
LIMN
-1.16%
US
CDNA
+3.02%
US
QDEL
+4.66%
benzinga_article·
US
LIMN
-1.16%
US
CDNA
+3.02%
US
QDEL
+4.66%

U.S. stock market midday update: Liminatus Pharma up 15.09%, trading volume surges, market sentiment is high but beware of volatility risks

Price Alert·
US
LIMN
-1.16%
Price Alert·
US
LIMN
-1.16%

Liminatus Pharma | 10-K: FY2025 Revenue: USD 0

Earnings Watch·
US
LIMN
-1.16%
Earnings Watch·
US
LIMN
-1.16%

Liminatus Pharma Announces Planned Phase 1 Clinical Trial of IBA101, a Next-Generation CD47 Blocking Antibody | LIMN Stock News

StockTitan·
US
LIMN
-1.16%
US
PBE
+1.60%
US
BBH
+0.96%
StockTitan·
US
LIMN
-1.16%
US
PBE
+1.60%
US
BBH
+0.96%

12 Health Care Stocks Moving In Tuesday's Intraday Session

benzinga_article·
US
LIMN
-1.16%
US
IBBQ
+2.43%
US
BIB
+4.98%
benzinga_article·
US
LIMN
-1.16%
US
IBBQ
+2.43%
US
BIB
+4.98%

Pre-market hot trades in US stocks: Liminatus Pharma up 17.00% in pre-market; Masterbeef down 13.79% in pre-market

Price Alert·
US
LIMN
-1.16%
US
MB
-4.55%
Price Alert·
US
LIMN
-1.16%
US
MB
-4.55%

U.S. Stock Movement Update: Neo-Concept surged 115%, Quince Therapeutics rose 75%, Liminatus Pharma fell 52%

Price Alert·
US
NCI
+6.75%
US
QNCX
+0.93%
US
DXST
-4.81%
Price Alert·
US
NCI
+6.75%
US
QNCX
+0.93%
US
DXST
-4.81%
© 2026 Longbridge｜Disclaimer